Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvs crawled date : 2021 - 07 - 08 save search
Agenus Sets Sights on New California Site Near Genentech
Published: 2021-07-08 (Crawled : 20:00) - biospace.com/
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: 0.12%
H: 0.41%
C: 0.33%
JNJ | $147.59 0.05% -0.56% 72K
|
Health Technology
|
| O: -0.42%
H: 0.45%
C: 0.23%
set
Insights on the Osteoarthritis Treatment Global Market to 2029 - Featuring Sanofi, GlaxoSmithKline and Anika Therapeutics Among Others
Published: 2021-07-08 (Crawled : 14:00) - prnewswire.com
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: 0.12%
H: 0.41%
C: 0.33%
JNJ | $147.59 0.05% -0.56% 72K
|
Health Technology
|
| O: -0.42%
H: 0.45%
C: 0.23%
GSK | $40.5 -0.39% -0.86% 4.9K
|
Health Technology
|
| O: -0.89%
H: 0.35%
C: 0.23%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -0.16%
H: 0.18%
C: 0.08%
treatment osteoarthritis
Molecular Partners Reports Continued Progress of Ensovibep Global Clinical Program; Positive in vitro Data Demonstrating Maintained Inhibition of Delta and All Other Known Variants of Concern of SARS-CoV-2
Published: 2021-07-08 (Crawled : 06:00) - globenewswire.com
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: 0.12%
H: 0.41%
C: 0.33%
positive molecular ensovibep sars-cov-2 in vitro
Gainers vs Losers
| 44% | 56% |
Top 10 Gainers
KAVL | $6.3 135.96% 51.63% 190K
|
Wholesale Trade
PALI | $4.16 0.97% 49.07% 2.7M
|
Manufacturing
SPCB | $0.4004 45.07% 44.2% 11M
|
Electronic Technology
JAGX | $0.1188 31.56% 35.59% 12M
|
Health Technology
HUBC | $1.95 50.0% 33.67% 4.7M
|
n/a
SNGX | $0.47 21.73% 28.68% 2.7M
|
Health Technology
PRSO | $1.27 -1.55% 27.53% 7.4M
|
Manufacturing
BRTX | $1.32 -1.49% 20.71% 3.3M
|
Professional, Scientific, and T...
ONVO | $1.35 33.65% 19.83% 260K
|
Health Technology
ITCI | $64.76 -1.7% 15.38% 690K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.